Faculty profile

Seonaid Nolan

ResearcherDepartment of MedicineUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Seonaid Nolan

Researcher

Department of Medicine

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
40 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (6 CIHR), most recently in 2026.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

103

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Overdose Addiction Substance Use Health Systems Indigenous Cultural Supports Indigenous Health Clinical Trials Hiv/Aids

Latest papers

Engaging communities in recovery: Evaluation of a patient and family advisory committee supporting implementation of the Road to Recovery model of substance use care in British Columbia
Drug and Alcohol Dependence Reports · 2026
Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series
Drug and Alcohol Dependence Reports · 2026
Patient experiences and perceived efficacy of a newly implemented hospital-based withdrawal management unit in Vancouver, Canada: findings from the Road to Recovery evaluation
Addiction Science & Clinical Practice · 2026

All 103 publications

Latest funding

Engagement-focused contingency management for the treatment of opioid use disorder: a randomized controlled trial
CIHR · 2026 · Co-investigator
$910,350
Embedding Indigenous research evaluation and governance within British Columbia's Road to Recovery substance use care program.
CIHR · 2026 · Nominated PI
$948,600
Target Trial Emulations of Novel Prescribing Practices for Opioid Use Disorder in the Context of a Volatile Drug Supply
CIHR · 2026 · Co-investigator
$794,990

All 23 grants and awards

103 publications.

Engaging communities in recovery: Evaluation of a patient and family advisory committee supporting implementation of the Road to Recovery model of substance use care in British Columbia

Chang D, Nolan S, Morgan J, Ryan A, Barton C, Chippeway R, Hall N, Gregory C, Mundel E, De Wolfe T

Drug and Alcohol Dependence Reports2026

DOI: 10.1016/j.dadr.2026.100444

Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series

Wong A, Nolan S, Bach P, Janssen RM, De Wolfe TJ, Dickhout P, Beauchesne R, Yang F, Johnson C, Carter A

Drug and Alcohol Dependence Reports2026

DOI: 10.1016/j.dadr.2026.100439

Patient experiences and perceived efficacy of a newly implemented hospital-based withdrawal management unit in Vancouver, Canada: findings from the Road to Recovery evaluation

Roberge S, Nolan S, Johnson C, Dickhout P, Abramowich A, De Wolfe T, Janssen R, Mundel E, Ryan A, Haynes I

Addiction Science & Clinical Practice2026

DOI: 10.1186/s13722-026-00671-5

Safer supply deprescribing during a toxic drug poisoning crisis in Vancouver, Canada.

Norton A, Hayashi K, Sayre EC, Nolan S, Strike C, Milloy MJ, Kerr T

Drug and alcohol dependence2026

DOI: 10.1016/j.drugalcdep.2026.113274 PMID: 42470805

Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program.

Mihic T, Socias ME, McCrae K, Johnson C, Nolan S, Grant C, Sutherland C, Fairbairn N

Drug and alcohol review2026

DOI: 10.1111/dar.70062 PMID: 41186078

Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020

Jackson E, Bach P, Socias ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S

Drug and Alcohol Dependence20257 citations

DOI: 10.1016/j.drugalcdep.2025.112703

Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study

Guyatt P, Babe G, Gayowsky A, Rosic T, Rodrigues M, Bach P, Perez R, de Oliveira C, Samet JH, Kerkerian G

Drug and Alcohol Dependence Reports20252 citations

DOI: 10.1016/j.dadr.2025.100368

Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada.

Young S, Fairbairn N, Cui Z, Bach P, Mok WY, Budau J, Slaunwhite A, Ti L, Hayashi K, Nolan S

Addiction (Abingdon, England)2025Senior author

DOI: 10.1111/add.16760 PMID: 39871812

Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational study.

Kurz M, Guerra-Alejos BC, Hossain MB, Min JE, Yan R, Bruneau J, Catherine NLA, Greenland S, Gustafson P, Hedden L, Karim E, McCandless L, Nolan S, Platt RW, Bach P, Seaman S, Siebert U, Socías ME, Nosyk B

BMJ open2025

DOI: 10.1136/bmjopen-2024-098317 PMID: 41093336

Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: The FASTER-BUP udy.

Socias ME, Dickhout P, Langlois J, Grant C, Nolan S

Drug and alcohol dependence2025Senior author

DOI: 10.1016/j.drugalcdep.2025.112798 PMID: 40716384

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Overdose Dear Professor Nolan, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Engaging communities in recovery: Evaluation of a patient and family advisory committee supporting implementation of the Road to Recovery model of substance use care in British Columbia" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Embedding Indigenous research evaluation and governance within British Columbia's Road to Recovery substance use care program." (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Seonaid Nolan

Research

Latest papers

Latest funding

Engaging communities in recovery: Evaluation of a patient and family advisory committee supporting implementation of the Road to Recovery model of substance use care in British Columbia

Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series

Patient experiences and perceived efficacy of a newly implemented hospital-based withdrawal management unit in Vancouver, Canada: findings from the Road to Recovery evaluation

Safer supply deprescribing during a toxic drug poisoning crisis in Vancouver, Canada.

Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program.

Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020

Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study

Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada.

Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational study.

Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: The FASTER-BUP udy.

Evaluating Longitudinal Evidence for using health incentiVes to Address and Treat Opioid Use Disorder Effectively (The ELEVATE Study)

Frequent collaborators

Evan Wood

Nadia Fairbairn

Lianping Ti

Kanna Hayashi

Thomas Kerr

Julio Montaner

Paxton Bach

Jan Klimas

Keith Ahamad

Cheyenne Johnson

Britt Dennis

Rolando Barrios

Amanda Slaunwhite

Kora DeBeck

Lindsey Richardson

Andrew Kestler

Tara Taylor

Hudson Reddon

Jane Buxton

Jessica Moe

Scott Harrison

Jade Boyd

Tea Rosic

Emma Garrod

Frank Scheuermeyer

Samantha Young

Kathryn Dong

Raoul Daoust

Zainab Samaan

Bohdan Nosyk

Elizabeth Dogherty

Harmony Johnson

Hasina Samji

Jennifer Gibson

Mark Lysyshyn

Paul Gustafson

Lindsay Hedden

Aaron Orkin

Grant Innes

Eric Grafstein